Pharmaceutical

Ethris shares positive data with mRNA drug following new funding    

ETH47 is a type III interferon-encoding mRNA drug that could be used to treat respiratory diseases including uncontrolled asthma.

Jun 26, 2024 - 04:00
Ethris shares positive data with mRNA drug following new funding    
ETH47 is a type III interferon-encoding mRNA drug that could be used to treat respiratory diseases including uncontrolled asthma.
Read the original article

Tags:

Previous Article

Pharma packaging solutions, design and companies

Next Article

Merck KGaA abandons Phase III trial for $1.08bn head & neck cancer drug

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

FDA approves Teva Pharmaceuticals’ AUSTEDO XR for TD and HD chorea

FDA approves Teva Pharmaceuticals’ AUSTEDO XR for TD an...

May 31, 2024

CD70 CAR-T by UTC Therapeutics for Follicular Lymphoma:...

Aug 10, 2023

Opinion: I grew up in one of Africa’s largest informal settlements. Now I’m helping heal it

Opinion: I grew up in one of Africa’s largest informal ...

Nov 25, 2023